Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge.
about
Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous ClearanceImmunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virusNew perspectives for preventing hepatitis C virus liver graft infection.Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C VirusAltered Glycosylation Patterns Increase Immunogenicity of a Subunit Hepatitis C Virus Vaccine, Inducing Neutralizing Antibodies Which Confer Protection in Mice.T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates.Immunization With a Subunit Hepatitis C Virus Vaccine Elicits Pan-Genotypic Neutralizing Antibodies and Intrahepatic T-Cell Responses in Nonhuman Primates.Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo.The Neutralizing Face of Hepatitis C Virus E2 Envelope Glycoprotein.Conformational Flexibility in the CD81-Binding Site of the Hepatitis C Virus Glycoprotein E2.Novel methods to prevent HCV transmission
P2860
Q28552909-51E8CCA2-2339-48E7-A803-22D6103D31B7Q28604286-8220E4BD-194C-4A52-B2D0-B5B280192E42Q37015805-C6FEC1C0-ED97-4560-8D56-F259E78D360AQ37252935-45BCB327-A76E-456F-917B-61286AA2C0D1Q37415463-2BF5FB62-8585-4720-9472-CF64DD255715Q38758212-F4DBC907-47E5-41C5-9454-1012F4E97AB4Q40248234-409EFCF0-BBED-4143-9DB7-52E2EC72937AQ45324948-40444D4D-9D3E-4005-92D3-E0F31D4BA6BBQ45325612-E80CD052-8EFD-43A4-86BC-FB1DC7D9488FQ55299977-08898C87-30E8-4E17-9065-EE478975210EQ55383950-62EC7145-19BA-42E6-994A-D9EB52034FF6Q58439383-B7132188-CC37-4784-821D-C56B088C746D
P2860
Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Monoclonal anti-envelope antib ...... d hepatitis C virus challenge.
@en
type
label
Monoclonal anti-envelope antib ...... d hepatitis C virus challenge.
@en
prefLabel
Monoclonal anti-envelope antib ...... d hepatitis C virus challenge.
@en
P2093
P2860
P356
P1433
P1476
Monoclonal anti-envelope antib ...... d hepatitis C virus challenge.
@en
P2093
Ali Farhoudi
Arvind H Patel
Freya Van Houtte
Isabelle Desombere
Jane A McKeating
Laura Heydmann
Lieven Verhoye
Patrick Pessaux
Samira Fafi-Kremer
Sarah Cole
P2860
P304
P356
10.1002/HEP.28428
P407
P577
2015-12-28T00:00:00Z